2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Johnny Kao: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer erlotinib + celecoxib - Cancer of the Pharynx, Cancer of the Larynx | Phase 1 / Phase 2 | Completed | Johnny Kao | 15 | 2007-02-01 | 2017-04-10 |
| Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer Cetuximab, Hydroxyurea, Fluorouracil - Head and Neck Cancer, Cancer of the Pharynx | Phase 2 | Completed | Johnny Kao | 33 | 2007-02-01 | 2018-03-13 |
Head and Neck Neoplasms (2) · Laryngeal Neoplasms (2) · Paranasal Sinus Neoplasms (2) · Pharyngeal Neoplasms (2) · Nose Neoplasms (1)
Celecoxib (1) · Cetuximab (1) · Erlotinib Hydrochloride (1) · Fluorouracil (1) · Hydroxyurea (1) · Radiotherapy (1)
United States (2)